The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery
Key facts
- Who runs it
- Nanjing First Hospital, Nanjing Medical University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 4
- People taking part
- 40 people, planned
- Started
- 20 Jul 2025
- Expected to end
- 30 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Tramadol
- bupivacaine liposome (ultrasound-guided high iliofascial space block)
- Record updated
- 15 July 2025
Who can take part
- Age
- 65 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patients with hip fractures scheduled for surgical treatment (including femoral neck fractures, intertrochanteric fractures, and fractures more than 5 cm below the lesser trochanter of the femur)
- Age ≥65 years
- American Society of Anesthesiologists (ASA) grade I - III
- The patient or family member signed the informed consent form
Who cannot take part
- Preoperative delirium or the use of delirium-related medications (such as olanzapine)
- Have a clear history of mental illness or are taking psychotropic drugs
- A history of acute cerebrovascular disease (cerebral infarction or cerebral hemorrhage) within 6 months
- Patients requiring sedation or postoperative coma due to the condition
- Allergy to amide local anesthetics
- Severe arrhythmia or liver or kidney dysfunction
- Compound injuries (such as combined fractures of the head, chest, pelvis, or limbs)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To explore the effects of bupivacaine liposomes in preemptive analgesia for iliofascial block on postoperative pain and postoperative delirium in elderly patients with hip fractures, to optimize perioperative analgesia strategies, to reduce the incidence of postoperative delirium, and to improve patient prognosis.
The 2 groups in the trial
- intramuscularlyPlacebo, for comparison
The elderly patients with hip fractures who were randomly divided into the control group were injected tramadol 100mg intramuscularly.
Treatment: Tramadol
- ultrasound-guided high iliofascial space blockTreatment being tested
The elderly patients with hip fractures who were randomly divided into the experimental group were given ultrasound-guided high iliofascial space block
Treatment: bupivacaine liposome (ultrasound-guided high iliofascial space block)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Effect of Bupivacaine Liposome Preemptive Analgesia on Postoperative Pain and Delirium in Elderly Patients Undergoing Hip Fracture Surgery: A Randomized, Parallel Controlled Prospective Clinical Study
- Record updated
- 15 July 2025